Portfolio

Your missing guide to breakthrough biotech

Using generative AI to de novo design breakthrough biologics

Supporting people, tools, and infrastructure to accelerate scientific progress

An integrated suite of cells, genes, and software to power advanced genetic design

World-leading partner for integrated drug discovery services

Organism selection as an engineering discipline

Single-source-of-truth platform for biological data and analysis

Evoking neuronal activity to improve the lives of Alzheimer’s patients

Engineering modern tools to create a world where bioprocess is never the bottleneck

Backing bold entrepreneurs building the future through technology

National Security Commission on Emerging Biotechnology

Products and services to help customers optimize their workflows and overcome complex challenges in areas of life science research

Unlocking the future of medicine by engineering CRISPR-based therapeutics that are safe and effective enough to transform everyone's lifetime risk for disease

Combining machine learning and biology to unlock solutions to complex challenges in protein design

Testing millions of candidates to build best-in-class immunotherapies

Fully-equipped labs and community spaces for growing biotech startups

Targeting the immune-regulating neuronal circuit to treat autoimmune and inflammatory diseases

Digitizing our ability to read, map, and write smell

Systematically identifying the best new drug creation opportunities with predictive AI and a decentralized R&D model

Tailoring precision remediation solutions to restore land to its productive potential

Reconstructing drug discovery with the blueprint of RNA Architecture

Develops cutting-edge immune-system compatible cell therapies

Optimizing transgenic design with introns to make un-makeable proteins

Awakening the physical world with Infrastructure AI solutions

Developing gene therapies with viral precision delivery systems for neurological disorders

Opening vast new inference AI markets with energy efficient analog computing power

Fully-integrated space observation systems

Advancing gut-targeted drugs that harness the potential of the gut-organ axis

Scaling nuclear energy for heavy industrial power and clean hydrocarbon fuel production

Pioneering Precision-Linked Proteomimetics to address intractable, intracellular targets

Reprogramming the brain's neuroimmune system to treat CNS conditions

Pioneering potassium-ion batteries for domestic energy resilience

Vertically integrating development and manufacturing of unmanned defense systems in America

Diagnostics that use AI to interpret solid cancer tumors and predict treatment response

Modeling complex gene synergies to find combinatorial cures for disease

Supporting founders driving structural change in healthcare and financial services

Programmable, targeted RNA therapies to advance a new class of safe, effective medicines for patients around the world

Helping more patients identify, monitor, and treat cancer sooner with liquid biopsies

Bringing AI algorithms built by researchers across the world to the clinic

DNA synthesis without cells for faster production and clinical scale-up

Building semi-autonomous AIs to scale, accelerate, and democratize scientific research

Helping academic labs create better AI models and do more science

Decoding disease complexity with unmatched resolution

Setting a new standard in acute care with inhaled therapies that work in seconds, not hours

Developing next-generation induced-proximity medicines

Unlocking true precision medicine with a blood-based approach

Going beyond single-cell therapies to engineer functional iPSC-derived tissue replacements that restore neural networks

One platform to coordinate AI models, virtual screening workflows, and experimental requests for drug discovery

Rationally engineering nature-inspired novel small molecule therapeutics to treat CNS disorders.

Unmatched design freedom and manufacturing simplicity

Leveraging AI to design and deploy advanced materials & engineering products

AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need

Funding the modernization of critical industries

Tackling tumor heterogeneity by utilizing our platform to design combination therapies

Enabling experiments on living cells with newfound clarity

Enabling experiments on living cells with newfound clarity

Pioneering real time healthcare delivery with a breakthrough multi-analyte biosensor

Leading worldwide R&D to advance the frontier of material exploration

Enabling the observation of living biology over time with non-destructive cellular imaging

European investment club by bio founders, for bio founders

Solving the cell therapy supply shortage

Harnessing prebiotic fibers from human milk to nourish the microbiome

Venture fund investing in lean biopharma startups founded by rare disease parents

Making organ-on-a-chip modeling viable with streamlined hardware and software workflows

Funding the bioacceleration‍

Cutting-edge AI to create digital twins of clinical trial participants and streamline clinical development

De novo miniprotein design to combine the most desirable characteristics of small molecules and biologics

Overcoming cancer treatment resistance to save lives